Judge Dismisses Zantac Claims on Federal Preemption
In two recent rulings, U.S. District Court Judge Robin L Rosenberg dismissed a host of claims against Zantac defendants based on federal pre-emption. In short, preemption is a doctrine that can shield drug manufacturers from liability in certain cases where they follow the FDA requirements for an approved drug or medication.